TransCorp Spine Receives FDA 510(k) Clearance for the SpinePortTM Spinal Access System for Minimally-‐Invasive Access and Visualization of the Cervical Spine
Ada, Michigan – June 12, 2012 – TransCorp Spine announced today that it recevied FDA 510(k) clearance for its SpinePort Spinal Access System. The SpinePort System provides direct access and visualization to aide surgeons in treating cervical spine pathologies through a transcorporeal microdecompression procedure. The SpinePort System can also be used to harvest local autograft bone eliminating the need for a second inicision during cerv...
Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.
Hit the SUBSCRIBE button at the top of the homepage.